Allows Medicare to cover external infusion pumps and home infusion drugs that do not meet its usual home-use test, when the drug is given under a health professional's supervision and a qualified home infusion supplier provides it.

• Treats external infusion pumps and associated home infusion drugs as meeting Medicare's durable medical equipment home-use requirement when three criteria are met.
• Requires that FDA prescribing information say the drug must be given by or under a health professional's supervision, that a qualified home infusion therapy supplier administers or supervises it in the patient's home, and that it is infused at least 12 times per year, either intravenously or subcutaneously or at rates requiring a pump.
• Takes effect with the first calendar quarter beginning at least one year after enactment.
• Directs the Secretary of Health and Human Services to ensure patients are notified of their cost sharing for home infusion compared with other infusion settings.

• Ways and Means Committee (House)
• Energy and Commerce Committee (House)

Health